Research Article
GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer
Table 1
Univariate and multivariate cox regression analyses of risk factors associated with overall survival based on TCGA datasets.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age | 306 | | | | | ≤50 | 188 | Reference | | | | >50 | 118 | 1.289 (0.810-2.050) | 0.284 | | | T stage | 243 | | | | | T1 & T2 | 212 | Reference | | | | T3 & T4 | 31 | 3.863 (2.072-7.201) | <0.001 | 5.924 (2.166-16.200) | <0.001 | Clinical stage | 299 | | | | | Stage I & stage II | 231 | Reference | | | | Stage III & stage IV | 68 | 2.369 (1.457-3.854) | <0.001 | 0.749 (0.274-2.045) | 0.573 | GLTP | 306 | | | | | Low | 153 | Reference | | | | High | 153 | 0.550 (0.343-0.882) | 0.013 | 0.455 (0.253-0.819) | 0.009 |
|
|